Should we measure asymmetric dimethylarginine in patients with coronary artery disease?
- PMID: 17259245
- DOI: 10.1373/clinchem.2006.078881
Should we measure asymmetric dimethylarginine in patients with coronary artery disease?
Comment on
-
Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).Clin Chem. 2007 Feb;53(2):273-83. doi: 10.1373/clinchem.2006.076711. Epub 2006 Dec 21. Clin Chem. 2007. PMID: 17185364
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
